These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39390116)
21. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study. Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016 [TBL] [Abstract][Full Text] [Related]
22. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys. Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520 [TBL] [Abstract][Full Text] [Related]
23. Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6. Wang W; Yue Z; Tian Z; Xie Y; Zhang J; She Y; Yang B; Ye Y; Yang Y PLoS One; 2018; 13(2):e0193340. PubMed ID: 29470526 [TBL] [Abstract][Full Text] [Related]
24. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix. Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239 [TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway. Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895 [TBL] [Abstract][Full Text] [Related]
26. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118 [TBL] [Abstract][Full Text] [Related]
27. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167 [TBL] [Abstract][Full Text] [Related]
28. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody. Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF mBio; 2021 Jan; 12(1):. PubMed ID: 33468698 [TBL] [Abstract][Full Text] [Related]
29. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins. Harden ME; Munger K Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850 [TBL] [Abstract][Full Text] [Related]
30. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043 [TBL] [Abstract][Full Text] [Related]
31. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058 [TBL] [Abstract][Full Text] [Related]
32. Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells. Shao Y; Shah PT; Su Q; Li S; Huang F; Wang J; Wang P; Wu C Front Cell Infect Microbiol; 2024; 14():1459572. PubMed ID: 39411320 [TBL] [Abstract][Full Text] [Related]
33. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6. Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926 [TBL] [Abstract][Full Text] [Related]
34. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B. Xun J; Du L; Gao R; Shen L; Wang D; Kang L; Chen C; Zhang Z; Zhang Y; Yue S; Feng S; Xiang R; Mi X; Tan X Theranostics; 2021; 11(14):6847-6859. PubMed ID: 34093857 [No Abstract] [Full Text] [Related]
35. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Li B; Hu Y; Ye F; Li Y; Lv W; Xie X Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590 [TBL] [Abstract][Full Text] [Related]
36. The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells. Liu Z; Teng L; Gao L; Wang H; Su Y; Li J Biochem Biophys Res Commun; 2018 Sep; 504(1):6-12. PubMed ID: 30170728 [TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711 [TBL] [Abstract][Full Text] [Related]
38. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions. Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417 [TBL] [Abstract][Full Text] [Related]
39. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes. Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718 [TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). McFarlane M; MacDonald AI; Stevenson A; Graham SV J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]